HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China

Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. We retrospectively analyzed the data of 14,608 postmenopausal women aged 45...

Full description

Saved in:
Bibliographic Details
Published in:BMC women's health Vol. 24; no. 1; pp. 68 - 6
Main Authors: Yin, Xiaorui, Zhang, Chunxue, Wu, Xiaoqing, Feng, Jing, Xie, Jingyan, Li, Yujuan
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 24-01-2024
BioMed Central
BMC
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test. Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51-60, 61-70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608). This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
AbstractList Abstract Background Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. Methods We retrospectively analyzed the data of 14,608 postmenopausal women aged 45–90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test. Results Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51–60, 61–70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608). Conclusions This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test. Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51-60, 61-70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608). This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021.BACKGROUNDCervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021.We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test.METHODSWe retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test.Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51-60, 61-70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608).RESULTSOur results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51-60, 61-70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608).This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.CONCLUSIONSThis study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test. Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged [less than or equal to] 50, 51-60, 61-70, and [greater than or equal to] 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608). This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
BackgroundCervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021.MethodsWe retrospectively analyzed the data of 14,608 postmenopausal women aged 45–90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test.ResultsOur results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged ≤ 50, 51–60, 61–70, and ≥ 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608).ConclusionsThis study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population.
Background Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who were tested for HPV in Nanjing First Hospital from 2019 to 2021. Methods We retrospectively analyzed the data of 14,608 postmenopausal women aged 45-90 years, who underwent HPV examination in Nanjing First Hospital between January 2019 and December 2021. All participants were tested for 23 HPV genotypes. We subsequently analyzed the infection rate and evaluated the distribution of HPV using the chi-square test. Results Our results showed that the HPV infection rate in postmenopausal women in Nanjing, China was 22.36%. In terms of age group, the infection rate was 19.54%, 24.30%, 26.58%, and 14.99% in those aged [less than or equal to] 50, 51-60, 61-70, and [greater than or equal to] 71 years, respectively. The most common HPV subtypes were HPV52 (22.1 3%), HPV58 (15.86%), HPV53 (14.17%), HPV16 (12.61%), and HPV81 (11.66%), in that order. The single-HPV infection rate was 14.23%, and the multiple-genotype infection rate was 8.14% (1189/14,608). Conclusions This study showed that in Nanjing, China, the different age groups of post-menopausal women could have different rates of HPV infection, and the most common types were HPV52, HPV58, HPV53, HPV16 and HPV81. These findings highlighted the importance of understanding the epidemiology of HPV infection in specific populations, such as postmenopausal women in Nanjing, China. The results could provide valuable information for healthcare professionals and policymakers to develop targeted prevention and screening strategies for reducing the burden of HPV-related diseases in this population. Keywords: HPV infection, Cervical cancer, Postmenopausal women, Genotypes, Chinese women
ArticleNumber 68
Audience Academic
Author Zhang, Chunxue
Li, Yujuan
Wu, Xiaoqing
Yin, Xiaorui
Feng, Jing
Xie, Jingyan
Author_xml – sequence: 1
  givenname: Xiaorui
  surname: Yin
  fullname: Yin, Xiaorui
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China
– sequence: 2
  givenname: Chunxue
  surname: Zhang
  fullname: Zhang, Chunxue
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China
– sequence: 3
  givenname: Xiaoqing
  surname: Wu
  fullname: Wu, Xiaoqing
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China
– sequence: 4
  givenname: Jing
  surname: Feng
  fullname: Feng, Jing
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China
– sequence: 5
  givenname: Jingyan
  surname: Xie
  fullname: Xie, Jingyan
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China
– sequence: 6
  givenname: Yujuan
  surname: Li
  fullname: Li, Yujuan
  email: lyj0324nj@163.com
  organization: Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, No.68, ChangLe Road, Nanjing, 210006, China. lyj0324nj@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38267981$$D View this record in MEDLINE/PubMed
BookMark eNptkk9vFCEYxompsX_0C3gwk3jx4FRgmAFOptmobdKoB_XigbwwsMtmBkaYqfHby3Zr7RpDCPDyex_g5TlFRyEGi9Bzgs8JEd2bTKjEbY0pK11iVotH6IQwTutOcHb0YH6MTnPeYky4aPkTdNwI2nEpyAn6fvn5WzUlewODDcZWEPqq93lOXi-zj6EyG0hgZptK0Jtc-VBNMc-jDXGCJcNQ_YxlUbkUx-ojhK0P69fVauMDPEWPHQzZPrsbz9DX9---rC7r608frlYX17VpSTvXjjIKVIqGsqbDLROaOUyNtOA66pjkwHTXSd04pjVop3uhRc8Ea3jbcCyaM3S11-0jbNWU_Ajpl4rg1W0gprWCVC4_WOXA9I5YbrVuGaYCCHW9NQZjy6gmfdF6u9eaFj3a3tgwJxgORA93gt-odbxRBAssGe-Kwqs7hRR_LDbPavTZ2GGAYOOSFZVEtIUmtKAv_0G3cUmh1KpQtO2w7Aj7S63LHykfXCwHm52ouuCCErn74UKd_4cqrbejN8U4zpf4QQLdJ5gUc07W3T-SYLXzl9r7SxV_qVt_qV2pXzwsz33KH0M1vwGuxcz9
Cites_doi 10.1097/CEJ.0000000000000822
10.1002/cam4.2017
10.1016/S0140-6736(05)67069-9
10.3390/ijms24010811
10.3389/fpubh.2021.710209
10.7314/APJCP.2013.14.10.5861
10.3390/v13071342
10.3802/jgo.2016.27.e21
10.1016/S0002-9343(97)00177-0
10.7150/jca.57993
10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
10.3390/v12040380
10.1002/jmv.25331
10.1111/j.1552-6909.2001.tb01548.x
10.1128/JCM.02274-14
10.1016/S0140-6736(20)30157-4
10.3332/ecancer.2015.526
10.1186/s12905-021-01217-4
10.1002/cncy.22760
10.1016/j.annepidem.2009.01.023
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024
DBID NPM
AAYXX
CITATION
3V.
7R6
7RV
7X7
7XB
888
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PIMPY
PQEST
PQGEN
PQQKQ
PQUKI
PSYQQ
QXPDG
7X8
5PM
DOA
DOI 10.1186/s12905-024-02904-8
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
GenderWatch
Nursing & Allied Health Database (ProQuest)
Health & Medicine (ProQuest)
ProQuest Central (purchase pre-March 2016)
GenderWatch (Alumni Edition)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest Women's & Gender Studies
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
Diversity Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Diversity Collection
ProQuest Central Korea
ProQuest Medical Library (Alumni)
GenderWatch (Alumni Edition)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
GenderWatch
ProQuest One Academic UKI Edition
ProQuest Women's & Gender Studies
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1472-6874
EndPage 6
ExternalDocumentID oai_doaj_org_article_facdf1e7ebb54028a12fdecc00e42b1d
A782196874
10_1186_s12905_024_02904_8
38267981
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-5E
-5G
-A0
-BR
04C
0R~
23N
2WC
3V.
53G
5VS
6J9
6PF
7R6
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACHQT
ACIHN
ACRMQ
ADBBV
ADINQ
ADOJX
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BMSDO
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
DU5
E3Z
EBD
EBLON
EBS
ECF
ECT
EIHBH
ESX
EX3
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICW
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
QXPDG
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQGEN
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c515t-f242a298324360548b4f02c9eaf62f497a4b669b3f4bbabfbd8b8d48437537083
IEDL.DBID RPM
ISSN 1472-6874
IngestDate Tue Oct 22 15:14:44 EDT 2024
Tue Sep 17 21:29:54 EDT 2024
Thu Oct 24 01:52:29 EDT 2024
Thu Oct 10 23:04:07 EDT 2024
Tue Nov 19 21:41:06 EST 2024
Tue Nov 12 23:50:24 EST 2024
Thu Nov 21 22:49:41 EST 2024
Sat Nov 02 12:28:59 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Chinese women
HPV infection
Postmenopausal women
Cervical cancer
Genotypes
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-f242a298324360548b4f02c9eaf62f497a4b669b3f4bbabfbd8b8d48437537083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809476/
PMID 38267981
PQID 2925609614
PQPubID 42554
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_facdf1e7ebb54028a12fdecc00e42b1d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10809476
proquest_miscellaneous_2918510812
proquest_journals_2925609614
gale_infotracmisc_A782196874
gale_infotracacademiconefile_A782196874
crossref_primary_10_1186_s12905_024_02904_8
pubmed_primary_38267981
PublicationCentury 2000
PublicationDate 2024-01-24
PublicationDateYYYYMMDD 2024-01-24
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-24
  day: 24
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC women's health
PublicationTitleAlternate BMC Womens Health
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References Y Shen (2904_CR15) 2021; 21
GM Clifford (2904_CR14) 2005; 366
JM Walboomers (2904_CR7) 1999; 189
B Zhu (2904_CR21) 2019; 8
SK Zhang (2904_CR17) 2020; 42
R Ghittoni (2904_CR6) 2015; 9
N Muñoz (2904_CR3) 2006; 24
K Canfell (2904_CR18) 2020; 395
YJ Choi (2904_CR1) 2016; 27
L Koutsky (2904_CR5) 1997; 102
J Reid (2904_CR8) 2020; 30
M Kim (2904_CR19) 2021; 13
DM Parkin (2904_CR9) 2006; 24
2904_CR25
J Shen (2904_CR22) 2018; 52
H Jia (2904_CR20) 2021; 12
HC Low (2904_CR16) 2015; 53
S Sui (2904_CR13) 2013; 14
SY Tang (2904_CR12) 2021; 9
L Koutsky (2904_CR4) 2009; 19
G Bogani (2904_CR24) 2023; 32
MA Oyervides-Muñoz (2904_CR10) 2020; 12
A Schneider (2904_CR2) 1993; 69
M Li (2904_CR11) 2019; 91
G Gullo (2904_CR23) 2023; 24
References_xml – volume: 32
  start-page: 525
  issue: 6
  year: 2023
  ident: 2904_CR24
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0000000000000822
  contributor:
    fullname: G Bogani
– volume: 8
  start-page: 5373
  year: 2019
  ident: 2904_CR21
  publication-title: Cancer Med
  doi: 10.1002/cam4.2017
  contributor:
    fullname: B Zhu
– volume: 366
  start-page: 991
  year: 2005
  ident: 2904_CR14
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67069-9
  contributor:
    fullname: GM Clifford
– volume: 24
  start-page: 811
  year: 2023
  ident: 2904_CR23
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24010811
  contributor:
    fullname: G Gullo
– volume: 9
  start-page: 710209
  year: 2021
  ident: 2904_CR12
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2021.710209
  contributor:
    fullname: SY Tang
– volume: 14
  start-page: 5861
  year: 2013
  ident: 2904_CR13
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2013.14.10.5861
  contributor:
    fullname: S Sui
– volume: 13
  start-page: 1342
  year: 2021
  ident: 2904_CR19
  publication-title: Viruses
  doi: 10.3390/v13071342
  contributor:
    fullname: M Kim
– volume: 27
  start-page: e21
  year: 2016
  ident: 2904_CR1
  publication-title: J Gynecol Oncol
  doi: 10.3802/jgo.2016.27.e21
  contributor:
    fullname: YJ Choi
– volume: 52
  start-page: 493
  year: 2018
  ident: 2904_CR22
  publication-title: Zhonghua Yu Fang Yi Xue Za Zhi
  contributor:
    fullname: J Shen
– volume: 102
  start-page: 3
  year: 1997
  ident: 2904_CR5
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(97)00177-0
  contributor:
    fullname: L Koutsky
– volume: 12
  start-page: 4379
  year: 2021
  ident: 2904_CR20
  publication-title: J Cancer
  doi: 10.7150/jca.57993
  contributor:
    fullname: H Jia
– volume: 24
  start-page: 31
  issue: Suupl 3
  year: 2006
  ident: 2904_CR3
  publication-title: Vaccine
  contributor:
    fullname: N Muñoz
– volume: 189
  start-page: 12
  year: 1999
  ident: 2904_CR7
  publication-title: J Pathol
  doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  contributor:
    fullname: JM Walboomers
– volume: 69
  start-page: 165
  year: 1993
  ident: 2904_CR2
  publication-title: Genitourin Med
  contributor:
    fullname: A Schneider
– volume: 12
  start-page: 380
  year: 2020
  ident: 2904_CR10
  publication-title: Viruses
  doi: 10.3390/v12040380
  contributor:
    fullname: MA Oyervides-Muñoz
– volume: 91
  start-page: 473
  year: 2019
  ident: 2904_CR11
  publication-title: J Med Virol
  doi: 10.1002/jmv.25331
  contributor:
    fullname: M Li
– volume: 30
  start-page: 299
  year: 2020
  ident: 2904_CR8
  publication-title: J Obstet Gynecol Neonatal Nurs
  doi: 10.1111/j.1552-6909.2001.tb01548.x
  contributor:
    fullname: J Reid
– volume: 24
  start-page: 311
  issue: Suppl 3
  year: 2006
  ident: 2904_CR9
  publication-title: Vaccine
  contributor:
    fullname: DM Parkin
– volume: 53
  start-page: 550
  year: 2015
  ident: 2904_CR16
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02274-14
  contributor:
    fullname: HC Low
– volume: 42
  start-page: 252
  year: 2020
  ident: 2904_CR17
  publication-title: Zhonghua Zhong Liu Za Zhi
  contributor:
    fullname: SK Zhang
– volume: 395
  start-page: 591
  year: 2020
  ident: 2904_CR18
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30157-4
  contributor:
    fullname: K Canfell
– volume: 9
  start-page: 526
  year: 2015
  ident: 2904_CR6
  publication-title: Ecancer
  doi: 10.3332/ecancer.2015.526
  contributor:
    fullname: R Ghittoni
– volume: 21
  start-page: 80
  year: 2021
  ident: 2904_CR15
  publication-title: BMC Women’s Health
  doi: 10.1186/s12905-021-01217-4
  contributor:
    fullname: Y Shen
– ident: 2904_CR25
  doi: 10.1002/cncy.22760
– volume: 19
  start-page: 239
  year: 2009
  ident: 2904_CR4
  publication-title: Ann Epidemiol
  doi: 10.1016/j.annepidem.2009.01.023
  contributor:
    fullname: L Koutsky
SSID ssj0017857
Score 2.3772054
Snippet Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal women who...
Background Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of...
BackgroundCervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of postmenopausal...
Abstract Background Cervical cancer is strongly associated with human papillomavirus (HPV) infection. In this retrospective study, we analyzed the data of...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 68
SubjectTerms Age groups
Analysis
Care and treatment
Cervical cancer
Chinese women
Complications and side effects
Deoxyribonucleic acid
DNA
Epidemiology
Genotype
Genotypes
Health aspects
Hospitals
HPV infection
Human papillomavirus
Infections
Medical screening
Multiple births
Papillomavirus infections
Postmenopausal women
Prevention
Risk factors
Statistical analysis
Womens health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BT0gI8Sa0ICMhcYCoiePa42OBVntCSDyExMHyIxbtIbtquv-_M0521YgDFw57iZ1NMuPxfJPMfAPwFq3SMWsmw0tNza3ua5uirdtAzq8z0ZvAgeLqm_nyCz-fMU3OvtUX54RN9MCT4I6zjym3velDIHAh0bcyJ7pu0_RKhjaV3bfRu2Bq_n5g8MTsSmRQH4_8toUrkRX9bKNqXLihwtb_9558yyktEyZveaDzh_Bgho7idLrlR3CnHx7D_em9m5jKiZ7A79XXn2JzxSTebLPCD0kkJsed-1qJuGRoFheD2KxHzjWn8Hk70gUKKYPguhNBe-8l-bYPorTZfgo_zs--f1rVcwOFOhJMua4z-V8vLRmt6ihsURhUbmS0vSftZGWNV0FrG7qsQvAhh4QBk0LVURBjCJw9g4NhPfQvQHjfenVicoodIayEqDvTZeMt_SmhjFDB-5083WbiyXAlvkDtJuk7kr4r0ndYwUcW-X4mc1yXA6R5N2ve_UvzFbxjhTm2RNJK9HNBAd0wc1q5UwI_tL-gURUcLWaSBcXl8E7lbrbg0UnLYNASeqngzX6Yz-SstKFfb3kOoZ2WQJWs4Pm0QvaP1FHcZiy2FeBi7SyeeTkyXPwp_N6c9mmV0S__h5QO4Z4s676tpTqCg-urbf8K7o5p-7qYzA0b8Rwg
  priority: 102
  providerName: Directory of Open Access Journals
Title HPV prevalence and distribution characteristics in postmenopausal women from Nanjing, China
URI https://www.ncbi.nlm.nih.gov/pubmed/38267981
https://www.proquest.com/docview/2925609614
https://www.proquest.com/docview/2918510812
https://pubmed.ncbi.nlm.nih.gov/PMC10809476
https://doaj.org/article/facdf1e7ebb54028a12fdecc00e42b1d
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6RnpAQ4o2hRIuExAHc-LHdx7GUVkEIVImHkDis9uEtQdSJ4ub_M7O2o1rcOOTiXTu2Z2bnm_XMNwCvlObCR0FkeKHIqdV9roPXeenQ-dXSW-koUFx-kZ9_qPdnRJMjxlqYlLTv3eqo_XN11K5-pdzKzZVfjHlii4tPp5QXp7kUixnMEByOMfrw7UCqYzmWxyix6GinhaqQOf50wXNq0VcjqpZalRNvlEj7_12ab_imad7kDUd0fg_uDgiSnfR3eh9uNe0DuNNvv7G-qugh_FxefGebLXF5k-ky2wYWiCN3aG_F_JSoma1atll3lHKOUfSuwz9I3AyMyk8YLsG_0cW9Zanb9iP4dn729XSZD30Uco9o5TqP6IZtpdF2eY3RC1eOx6LyurEopMi1tNwJoV0duXPWRReUU4ErXmMsIxGjPYaDdt02T4FZW1p-LGPwNQKtoJSoZR2l1XhRBBsugzfj-zSbni7DpDBDCdMLwqAgTBKEURm8o1e-n0lU1-nAentpBoGbaH2IZSMb5xBdVsqWVQyoeEXR8MqVIYPXJDBDBolS8XaoK8AbJmorc4IYCJcZJXkGh5OZaEh-OjyK3AyG3JlKEybUCGIyeLkfpjMpOa1t1juag6AHdbKsMnjSa8j-kUZFy0BNdGfyzNMR1PpE8z1q-bP_P_U53K6S4pd5xQ_h4Hq7a17ArAu7OYYPHz7O0xbEPNnPX2AwHNo
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53801,53803
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RcgAJUd4EWjASEgdINw83to9tabWItqpEQUgcLD9iWESzq033_zPjJKtGvfWQy9rZxDsznm-8M98AvJeKVy5URIbns5Ra3afKO5XmFp1fKZwRlgLF6Tdx9lN-PiKanGqohYlJ-87Odpt_l7vN7E_MrVxcusmQJzY5Pz2kvDjFRTXZgLtosFk-ROn9vwdC7omhQEZWk5bOWqgOmeOlMp5Sk74ScbVQMh_5o0jbf3NzvuadxpmT11zR8dZtF_EIHvbgk-1344_hTt08gQfdyR3rCpKewq_p-Q-2WBINOFk9M41nnuh1-85YzI05ntmsYYt5S9nqGICvWnxApHVgVLnCcPf-i97xE4uNup_B9-Oji8Np2rdgSB0Cnas0oAc3hUKz5yUGPlxaHrLCqdqgfANXwnBbVcqWgVtrbLBeWum55CWGQQLh3XPYbOZN_RKYMbnheyJ4VyJG81JWpSiDMAq_FHGKTeDjIAi96Jg2dIxQZKU7CWqUoI4S1DKBA5LVeiaxZMcP5svfuv-ZdTDOh7wWtbUITAtp8iJ41Nksq3lhc5_AB5K0JltGcTrTlyTgCxMrlt5H-IQ7lBQ8ge3RTLRBNx4edEX3e0CrC0VwUiH-SeDdepjupLy2pp6vaA7iJdSEvEjgRada6yUNGpqAHCndaM3jEdS1yBA-6Nar29_6Fu5NL05P9MmXs6-v4X4RrSdPC74Nm1fLVb0DG61fvYmG9x-rrjCp
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xi4SQEO9HYAEjIXGAbF7e2Oa27G5VBKwq8RDSHiw_Yihi06rd_n9mnKTaiBsccqmdJu7MeL5xZ74BeCkVr12oiQzP5ym1uk-VdyotLDq_SjgjLAWK08_i9Ls8PiGanLdDLUxM2nd2vt_-Pt9v5z9jbuXy3GVDnlg2-3REeXGKizpb-pDtwFU02rwaIvX-HwQhD8RQJCPrbE3nLVSLzPFSOU-pUV-F2FooWYx8UqTu_3uDvuShxtmTl9zR5Nb_LOQ23OxBKDvs5tyBK017F250J3isK0y6B2fT2Te2XBEdOFk_M61nnmh2-w5ZzI25ntm8ZcvFmrLWMRDfrPEBkd6BUQULw138F3rJNyw27L4PXycnX46mad-KIXUIeC7SgJ7clArNn1cYAHFpechLpxqDcg5cCcNtXStbBW6tscF6aaXnklcYDgmEeQ9gt120zSNgxhSGH4jgXYVYzUtZV6IKwij8UsQrNoHXgzD0smPc0DFSkbXupKhRijpKUcsE3pG8tjOJLTt-sFj90P1PrYNxPhSNaKxFgFpKU5TBo-7mecNLW_gEXpG0Ndk0itSZvjQBX5jYsfQhwijcqaTgCeyNZqItuvHwoC-63wvWulQEKxXioARebIfpTspva5vFhuYgbkJtKMoEHnbqtV3SoKUJyJHijdY8HkF9i0zhg349_vdbn8O12fFEf3x_-uEJXC-jARVpyfdg92K1aZ7CztpvnkXb-wM4JTMp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HPV+prevalence+and+distribution+characteristics+in+postmenopausal+women+from+Nanjing%2C+China&rft.jtitle=BMC+women%27s+health&rft.au=Yin%2C+Xiaorui&rft.au=Zhang%2C+Chunxue&rft.au=Wu%2C+Xiaoqing&rft.au=Feng%2C+Jing&rft.date=2024-01-24&rft.pub=BioMed+Central&rft.eissn=1472-6874&rft.volume=24&rft.spage=1&rft_id=info:doi/10.1186%2Fs12905-024-02904-8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6874&client=summon